Article
MGMT Promoter Methylation and Parathyroid Carcinoma
23 Jul 2019
Abstract excerpt
Abstract Context Parathyroid carcinoma (PC) is extremely rare. Prognosis is poor, with no known evidence-based systemic therapies. We previously reported complete remission in a patient with metastasized parathyroid carcinoma and high tumor MGMT promoter methylation status who was treated with temozolomide. Objective To study MGMT promoter methylation status in an additional set of aggressive parathyroid tumors....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
